CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to evaluate the dose-related safety, tolerability, pharmacokinetics (PK) and pharmacological effects (PD) of CORT125134 and its active metabolite CORT125201 after single and multiple ascending oral doses of CORT125134 in healthy participants.
Epistemonikos ID: c9e3d485271542055e95626ae0d1e14c376b8a1a
First added on: May 21, 2024